Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;44(5):165-169.
doi: 10.18773/austprescr.2021.038. Epub 2021 Oct 1.

Approach to the diagnosis of secondary hypertension in adults

Affiliations
Review

Approach to the diagnosis of secondary hypertension in adults

Ranita Siru et al. Aust Prescr. 2021 Oct.

Erratum in

Abstract

Presentations that should raise suspicion of secondary hypertension include early-onset, severe or resistant hypertension. A suggestive family history or clinical clues can point to a specific secondary cause. The most common causes and associations are renal disease, primary aldosteronism and obstructive sleep apnoea. Medicines, illicit substances and alcohol may also be responsible. The assessment of patients begins with history taking and examination, to look for clinical clues. Laboratory tests include electrolytes, urea, creatinine and the aldosterone:renin ratio, urinalysis and the urine albumin:creatinine ratio. Abnormal results should prompt further investigation. Initial testing for primary aldosteronism is best done before starting potentially interfering antihypertensive drugs. If the patient is already taking interfering antihypertensive drugs that cannot be stopped, the interpretation of the aldosterone:renin ratio must consider the presence of those drugs. Specialist advice can be sought if needed.

Keywords: aldosteronism; antihypertensive drugs; blood pressure; hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: none declared

Figures

Fig
Fig
Effects of interfering drugs on aldosterone and renin

References

    1. Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2018;138:e484-594. 10.1161/CIR.0000000000000596 - DOI - PubMed
    1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press 2018;27:314-40. 10.1080/08037051.2018.1527177 - DOI - PubMed
    1. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016;101:1889-916. 10.1210/jc.2015-4061 - DOI - PubMed
    1. Hundemer GL. Primary aldosteronism: cardiovascular outcomes pre- and post-treatment. Curr Cardiol Rep 2019;21:93. 10.1007/s11886-019-1185-x - DOI - PubMed
    1. Gurgenci T, Geraghty S, Wolley M, Yang J. Screening for primary aldosteronism: How to adjust existing antihypertensive medications to avoid diagnostic errors. Aust J Gen Pract 2020;49:127-31. 10.31128/AJGP-07-19-4995 - DOI - PubMed

FURTHER READING

    1. Gabb G. What is hypertension? Aust Prescr 2020;43:108-9. 10.18773/austprescr.2020.025 - DOI - PMC - PubMed

LinkOut - more resources